Table 3.
Name (Number) P (Mechanism) a |
Compound’s Structure |
pKi | Ref. | Name (Number) P (Mechanism) a |
Compound’s Structure |
pKi | Ref. |
---|---|---|---|---|---|---|---|
Aripiprazole (25) FA a |
8.57 | [46] |
Norfenfluramine (36) AG |
6.82 | [47] | ||
BW-723C86 (26) AG |
7.2 | [48] |
Olanzapine (37) IA |
8.88 | [49] | ||
Clozapine (27) FA |
8.39 | [50] |
Quentiapine (38) FA |
6.81 | [50] | ||
CP-809,101 (28) AG |
8.22 | [51] |
R060-0175 (39) IA |
7.44 | [48] | ||
Ketanserin (29) FA |
9.67 | [52] |
Risperidone (40) IA |
9.69 | [50] | ||
Lorcaserin (30) AG |
6.95 | [53] |
RS-127,455 (41) FA |
6.03 | [48] | ||
MDL-100,907 (31) FA |
8.77 | [54] |
Saprogrelate (42) FA |
8.52 | [55] | ||
Mesulergine (32) FA |
7.34 | [56] |
SB-204,741 (43) FA |
5.00 | [57] | ||
Mianserin (33) FA |
8.15 | [58] |
SB-206,553 (44) FA |
5.64 | [59] | ||
Mirtazapine (34) IA |
7.78 | [60] |
SB-242,084 (45) FA |
6.07 | [61] | ||
Naftidrofuryl (35) IA |
6.20 | [55] |
WAY-161,503 (46) AG |
7.40 | [62] |
a Pharmacology: AG—agonist, IA—inverse agonist, PA—partial agonist, FA—full antagonist.